Best Doctors for Chemotherapy in Delhi NCR, India

Dr. Lalit Kumar is the Chairperson of Oncology & Bone Marrow Transplant at Artemis Hospital in Gurgaon, bringing over four decades of distinguished experience in hematologic oncology, stem cell transplantation, and medical oncology. Recipient of the prestigious Padma Shri Award in 2014, one of India's highest civilian honors, Dr. Kumar has made extraordinary contributions to advancing cancer care and transplant medicine. His academic credentials include an MBBS and MD from Sarojini Naidu Medical College, Agra, and a DM in Medical Oncology from Adyar Cancer Institute, Chennai, complemented by postdoctoral training at the Royal Postgraduate Medical School of Hammersmith Hospital, London, and a Fulbright Scholarship from the United States. Dr. Kumar's clinical expertise spans the full spectrum of hematologic malignancies and solid tumor oncology. He specializes in bone marrow and stem cell transplantation—both allogeneic and autologous—with particular proficiency in treating multiple myeloma, lymphoma, acute leukemia, and chronic leukemia. His work in neoadjuvant chemotherapy and targeted immunotherapy for advanced cancers has established him as a leading voice in the field. He is widely recognized for developing cost-effective treatment protocols that have made life-saving transplant procedures more accessible without compromising clinical outcomes. Prior to his current role, Dr. Kumar served as Professor and Head of the Department of Medical Oncology at AIIMS, New Delhi, where he consolidated his reputation as an educator and researcher. International patients from the Gulf region, Africa, and South Asia seek Dr. Kumar's care for complex hematologic and oncologic conditions. He has a proven track record managing cases referred from diverse geographic backgrounds and maintains a patient-centered approach that prioritizes compassionate communication and tailored treatment planning. His involvement with the Indo-British Health Initiative and memberships in the Institute of Women's Health (UCL) further reflect his commitment to advancing global oncology standards. Artemis Hospital, where Dr. Kumar leads the oncology and transplant division, is a premier multispecialty facility equipped with state-of-the-art diagnostic and therapeutic infrastructure. The hospital maintains rigorous quality standards and supports a robust international patient services desk, making it an ideal destination for overseas patients seeking specialized cancer and transplant care. For international patients considering bone marrow or stem cell transplantation, or seeking second opinions on complex hematologic and solid tumor cases, Artemis Hospital offers both world-class clinical expertise and a comprehensive support ecosystem to ensure smooth treatment and recovery.

Dr. Harit Kumar Chaturvedi is Chief Executive Officer and Clinical Head of Surgical Oncology at Indraprastha Apollo Hospital in New Delhi, bringing over 32 years of dedicated experience to the field of cancer surgery. He holds an M.Ch in Surgical Oncology from AIIMS New Delhi and completed his fellowship at Tata Memorial Hospital, Mumbai—credentials that establish him as one of India's most respected surgical oncologists. His clinical journey has been defined by a commitment to precision, innovation, and comprehensive cancer care across multiple organ systems. Dr. Chaturvedi's clinical portfolio spans the full spectrum of surgical oncology, including breast cancer, head and neck malignancies, lung, gastric, colorectal, pancreatic, renal, bladder, and esophageal cancers. He is a pioneer in robotic-assisted surgical oncology across South Asia, proficient in the da Vinci Xi robotic systems, and performs advanced procedures including cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS + HIPEC). His high-volume practice and mastery of both open and minimally invasive techniques enable him to offer individualized treatment plans tailored to each patient's cancer stage and overall health. International patients form a significant part of Dr. Chaturvedi's practice. He regularly treats patients from the Middle East, SAARC nations, CIS countries, and Africa, offering them access to world-class cancer care with the reassurance of fluent English communication, transparent treatment planning, and a patient-centric approach. Many international patients value his shared decision-making model, which ensures clarity at every stage of care and empowers patients to participate actively in their treatment journey. Indraprastha Apollo Hospital, where Dr. Chaturvedi leads the surgical oncology division, is a NABH and JCI-accredited institution equipped with state-of-the-art robotic surgical suites, advanced imaging, and dedicated intensive care facilities. The hospital's international patient services team facilitates visa assistance, accommodation coordination, and seamless follow-up care, making it an ideal destination for overseas patients seeking complex cancer surgery. Dr. Chaturvedi's leadership and his hospital's infrastructure combine to offer international patients the confidence that they are receiving treatment at par with leading global oncology centers. For patients seeking a surgical oncologist with deep expertise, international exposure, and a genuine commitment to shared decision-making, Dr. Chaturvedi represents the caliber of care that has established India as a leading destination for cancer surgery. His 32+ years of experience, combined with his mastery of cutting-edge surgical techniques and his recognition within major Indian and international oncology societies, ensure that international patients receive evidence-based, compassionate care aligned with global best practices.

Dr. Amita Mahajan is a Senior Consultant in Pediatric Hematology and Oncology at Indraprastha Apollo Hospital, New Delhi, with over 32 years of dedicated clinical experience in childhood blood disorders and cancers. She completed her MBBS and MD in Pediatrics from the All India Institute of Medical Sciences (AIIMS), New Delhi, followed by advanced international training: the MRCPCH from the Royal College of Paediatrics and Child Health, London, and specialist training (CCST) in Pediatric Oncology in the United Kingdom. This globally informed foundation enables her to deliver care aligned with the highest international standards. Dr. Mahajan's clinical expertise spans the full spectrum of pediatric hematology and oncology, including pediatric bone marrow transplantation, acute and chronic leukemias, thalassemia, sickle cell disease, aplastic anemia, hemophilia, and other complex blood disorders. She brings a multidisciplinary, evidence-based approach to each patient, ensuring comprehensive and compassionate management from diagnosis through long-term follow-up. International families seeking expert care for their children have consistently chosen Dr. Mahajan. She routinely treats patients from the Gulf region, Africa, and the broader South Asian community, providing culturally sensitive care and clear communication in English and Hindi. Her advisory roles with leading patient advocacy organizations—including CanKids, Leukemia Crusaders, and Thalassemics India—further demonstrate her commitment to supporting families navigating these serious conditions. At Indraprastha Apollo Hospital and Apollo Cancer Centre, Dr. Mahajan operates within a state-of-the-art environment equipped with advanced diagnostic and therapeutic facilities, including specialized oncology wards, ICU support, and modern imaging capabilities. The hospital's strong international patient support infrastructure, NABH accreditation, and access to tertiary-level pediatric services ensure families receive seamless, coordinated care. For families traveling internationally to secure expert pediatric oncology and hematology care, Dr. Mahajan offers decades of subspecialty experience combined with a proven track record of managing the most complex cases. Her position as an Executive Member of the Indian Pediatric Oncology Group further underscores her standing within the specialty.

Dr. Vinay Samuel Gaikwad is a dynamic and extensively trained surgical oncologist and Robotic & Laparoscopic GI surgeon at Fortis Hospital, Manesar, Gurugram. With over 24 years of rich clinical experience, he has been associated with some of the top hospitals in India, including Tata Memorial Hospital, Mumbai and MSKCC, New York. He completed his Fellowship in GI & HPB Surgical Oncology from Tata Memorial Hospital and his Hepatopancreatobiliary Oncology Training from MSKCC, New York. Dr. Gaikwad is proficient in performing the most advanced cancer surgeries including HIPEC and PIPAC, and has authored several articles for both national and international publications. He also specialises in GI and HPB Surgical Oncology and Peritoneal Surface Oncology. He presently leads a team of organ-based surgical oncologists and has been the first to start a hepatic artery infusion pump chemotherapy programme in India — a pioneering achievement that offers patients with liver-dominant metastatic colorectal cancer a powerful additional treatment option. Dr. Gaikwad is certified in HIPEC from ESSO Hannover, Germany and PIPAC from Tubingen, Germany, and has received training in minimally invasive colorectal surgery from AETF South Korea and upper GI surgery from IRCAD Taiwan. He has been recognised with the Most Trusted Oncologist Award 2023 by ASIA-GCC and the Blackswan Award for Excellence in Healthcare 2023-24 by Asia One.

Dr. Shishir Seth is a highly experienced Consultant in Hemato-Oncology and Bone Marrow Transplant at the Apollo Cancer Institute, Indraprastha Apollo Hospital, New Delhi. With over 24 years of clinical practice, he has earned a reputation as a trusted specialist for patients with complex blood disorders and hematologic malignancies seeking advanced transplant care. His comprehensive qualifications include an MD in Medicine, a DM in Clinical Hematology from Mumbai, and a prestigious Fellowship in Leukemia and Blood and Marrow Transplant from the Division of Hematology at Vancouver General Hospital, Canada—training that uniquely positions him to handle the most challenging cases. Dr. Seth's clinical expertise spans a broad spectrum of hemato-oncologic conditions and transplant procedures. He specializes in bone marrow transplantation in all its forms—allogeneic, autologous, matched sibling donor, matched unrelated donor, and haploidentical approaches—as well as the management of acute leukemias, myelodysplastic syndromes, lymphomas, and bone marrow failure disorders. His evidence-based approach and meticulous patient selection ensure optimal outcomes even in complex and high-risk scenarios. His ongoing involvement in clinical research and investigator-initiated studies reflects a commitment to advancing the field of hematology and transplant medicine. Dr. Seth has developed a strong track record treating international patients from the Gulf, Africa, and South Asia. His fluency in English and Hindi, combined with his experience managing diverse patient populations, ensures that patients from across borders receive culturally sensitive, comprehensive care. International patients appreciate his clear communication and his ability to coordinate complex pre-transplant evaluation and long-term post-transplant follow-up across continents. Indraprastha Apollo Hospital stands as one of India's premier tertiary-care institutions, equipped with state-of-the-art hematology and transplant facilities, dedicated ICU capacity, and a robust international patient support team. The hospital's NABH and JCI accreditations reflect its commitment to world-class clinical governance. Dr. Seth's base at this institution provides international patients access to high-volume, specialized care in a setting designed for seamless coordination and continuity of treatment. International patients considering bone marrow transplantation or complex hematologic treatment should know that Dr. Seth combines deep technical expertise with a patient-first philosophy. Gaf Healthcare can coordinate all aspects of your journey—from initial consultation and investigations to in-hospital care and long-term follow-up—ensuring a smooth, transparent experience from India.

Dr. Manish Jain is a distinguished Surgical Oncologist and Director & Unit Head of Gastrointestinal Oncosurgery at BLK-Max Super Speciality Hospital in New Delhi, India. With over 20 years of extensive clinical and surgical experience, Dr. Jain has established himself as a leading expert in the surgical management of gastrointestinal cancers. He holds qualifications including MBBS, MS in General Surgery, and DrNB in Surgical Gastroenterology, alongside certifications as a robotic surgeon and PIPAC (Pressurized Intraperitoneal Aerosol Chemotherapy) specialist. Dr. Jain specializes in the comprehensive surgical care of cancers affecting the esophagus, stomach, pancreas, gallbladder, bile ducts, liver, and colorectal organs. His proficiency spans both open and minimally invasive oncologic approaches, including robotic surgery using the Intuitive Da Vinci X and Xi platforms, as well as complex procedures such as cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy (CRS + HIPEC) for peritoneal surface malignancies. His technical expertise and strategic case management have made him a trusted name in gastrointestinal and hepatopancreatobiliary (HPB) oncosurgery across India. Dr. Jain is deeply committed to delivering personalized care to international patients seeking treatment in India. His hospital, BLK-Max, attracts patients from the Gulf Cooperation Council region, Africa, and South Asian countries seeking advanced oncologic surgery at competitive costs. He works closely with Gaf Healthcare to facilitate seamless consultations via video conferencing and WhatsApp for international patients, ensuring comprehensive pre-operative assessments and treatment planning regardless of geography. BLK-Max Super Speciality Hospital is recognized for its state-of-the-art surgical facilities, dedicated cancer center, and international patient services. The hospital maintains NABH accreditation and offers comprehensive ICU support, advanced imaging, and multidisciplinary tumor boards that ensure every oncology case receives collaborative expert review. For international patients, BLK-Max provides dedicated medical coordinators, translation services, and seamless logistics support to make treatment in New Delhi accessible and convenient. Dr. Jain is an active member of the Indian Association of Surgical Oncology, the International Hepato-Pancreato-Biliary Association, the Association of Surgeons of India, and the Association of Minimal Access Surgeons of India. His professional engagement reflects his commitment to evidence-based practice and continuous advancement in surgical oncology. International patients can expect world-standard oncologic surgery combined with the cost-effectiveness that makes New Delhi a preferred destination for complex gastrointestinal cancer treatment.

Dr. Sanjeev Kumar Sharma is the Director of Haemato-oncology and Bone Marrow Transplant at BLK-Max Super Speciality Hospital in New Delhi, one of India's leading tertiary-care centers. With over 20 years of clinical experience, he is widely recognized for his expertise in hematologic malignancies and complex bone marrow disorders. His career has been built on a foundation of rigorous training in clinical hematology and a deep commitment to evidence-based care, evidenced by his DM qualification and memberships in the Indian Society of Hematology and Blood Transfusion. Dr. Sharma's clinical practice encompasses the entire spectrum of bone marrow transplantation—autologous, allogeneic, haploidentical donor, and matched sibling and unrelated donor transplants. He is equally accomplished in managing acute leukemias, myelodysplastic syndromes, lymphomas, and bone marrow failure syndromes. His approach integrates reduced-intensity conditioning protocols and peripheral blood stem cell transplants to optimize outcomes while minimizing treatment burden. The breadth of his procedural repertoire and high case volumes position him as a trusted authority among peers and patients alike. International patients form a significant part of Dr. Sharma's practice, with patients traveling from the Gulf states, Africa, and across South Asia for consultation and treatment. He is known for his patient-centric philosophy, taking time to explain complex diagnoses and treatment options in clear language. His multilingual capability (English and Hindi) and familiarity with international patient protocols ensure a seamless experience for overseas visitors. Many families appreciate his compassionate yet direct communication style when discussing prognosis and individualized treatment plans. BLK-Max Super Speciality Hospital, where Dr. Sharma leads the Centre for Bone Marrow Transplant, is a NABH-accredited, multi-specialty facility with state-of-the-art oncology and hematology departments. The hospital houses dedicated BMT units with advanced isolators, comprehensive ICU support, and a robust international patient services desk. New Delhi's accessibility via multiple international airports and the availability of quality hotels and support services make it an ideal destination for complex hematological care. Patients under Dr. Sharma's care benefit not only from his clinical expertise but also from the hospital's integrated supportive care infrastructure, making it possible to manage even highly complex transplant scenarios with confidence.

Dr. Archit Pandit is Director of Surgical Oncology at Fortis Escorts, Okhla Road, New Delhi and is a highly accomplished and skilled surgical oncologist trained at the prestigious All India Institute of Medical Sciences (AIIMS), New Delhi. With over 15 years of clinical excellence, he has the distinction of performing more than 10,000 complex surgeries during his career spanning about a decade and a half. Internationally trained, Dr. Pandit has completed fellowships at the National Cancer Center, Tokyo (Japan) in minimally invasive gastroesophageal surgeries, and at Yonsei University Severance Hospital, Seoul (South Korea) in thoracic surgery and lung transplantation. He is also trained in Robotic Surgery at the Galaxy Care Institute, Pune, and underwent Colorectal Cancer Training with the Asian Endoscopic Task Force in Fuji, Japan. Additionally, he has completed courses in Advanced Laparoscopy and Pain & Palliative Medicine at AIIMS, New Delhi. Dr. Pandit has various publications in reputed international & national journals. Dr. Archit Pandit is a Gold Medalist (Best Outgoing MS Surgery, Karnataka, 2008) and has won Best Video Awards at the Indian Cancer Congress (2013) and ACOS (2016).

Dr. Dhwanee Thakkar is a Consultant in Pediatric Hematology and Oncology at Medanta - The Medicity in Gurugram, India. With over 14 years of dedicated clinical experience, she brings specialized expertise in diagnosing and managing complex hematological disorders in children. Her academic credentials include an MD in Pediatrics from VNSGU (2012), a Fellowship in Pediatric Hematology Oncology from the National Board of India, and an IAP Fellowship in Pediatric Hematology Oncology and Bone Marrow Transplant. Her international training includes a prestigious Fellowship in Haemostasis and Thrombosis at The Royal Infirmary of Edinburgh, Scotland (2017), which reflects her commitment to world-standard clinical practice. Dr. Thakkar's clinical expertise spans the full spectrum of pediatric hematological conditions, including leukemias, lymphomas, aplastic anemia, thalassemia, and sickle cell disease. She is particularly skilled in managing rare bleeding disorders, hemophilia, coagulation disorders, and primary immunodeficiencies. Her hands-on experience in Hematopoietic Stem Cell Transplantation and chemotherapy administration for pediatric malignancies demonstrates her capability to manage both routine and complex cases. Her special interest in hemophilia and rare bleeding disorders, combined with her academic recognition including gold medals for her MD postgraduate training, underscores her commitment to evidence-based pediatric care. International families seeking specialized pediatric hematology care benefit from Dr. Thakkar's experience treating patients from across India and abroad. She is fluent in English and Hindi, and works closely with Gaf Healthcare to facilitate seamless consultations for patients from the Gulf, Africa, and SAARC regions. Her patient-centered approach ensures that complex diagnoses are explained clearly to families, and treatment plans are tailored to each child's clinical and emotional needs. Medanta - The Medicity in Gurugram is a leading multispecialty tertiary care hospital, renowned for its comprehensive pediatric services and state-of-the-art facilities. The hospital houses dedicated pediatric oncology and hematology units with advanced diagnostic and therapeutic infrastructure, including bone marrow transplant capabilities. Accreditation and international clinical protocols ensure families receive care aligned with global standards. The hospital's international patient services team supports visa arrangements, accommodation, and coordination with Gaf Healthcare. International patients choosing Dr. Thakkar benefit from India's reputation for affordable, high-quality pediatric care. Initial consultations can be conducted virtually via video call, allowing families to discuss their child's condition and treatment options before travel. Medical records and diagnostic imaging are reviewed promptly, and second-opinion services are available for complex cases.

Dr. Manish Gaur is the Principal Consultant of Surgical Oncology at Max Super Speciality Hospital, Saket and Max Smart Super Speciality Hospital, Saket, New Delhi. He brings substantial training and experience in surgical oncology from premier Indian institutions, including AIIMS, New Delhi. After completing his MBBS at Kilpauk Medical College, Chennai (2011), Dr. Gaur went on to complete his MS in General Surgery at University College of Medical Sciences, New Delhi (2017), and his MCh in Surgical Oncology at All India Institute of Medical Sciences (AIIMS), New Delhi (2019). He further pursued international training including a Travelling Fellowship in INDO-UK Breast Oncoplasty (2025) and a Certificate Course (PIPAC) in Pleura and Peritoneum from the International Society for the Study of Pleura and Peritoneum (ISSPP) and the Indian Society of Peritoneal Surface Malignancies in Bengaluru (2024). Dr. Gaur's clinical expertise spans head and neck cancer surgery, breast cancer surgery (including breast conservation and oncoplastic/reconstructive procedures), thyroid and salivary gland tumour surgery, sentinel node biopsy, oncoplastic and reconstructive oncology, hyperthermic intraperitoneal chemotherapy (HIPEC), electrochemotherapy, and minimally invasive and precision oncology surgery.